Get the Daily Brief
Latest Biotech News
AI spots hidden arrhythmia: paroxysmal AF detected from sinus‑rhythm ECGs
Researchers developed AI software that detects paroxysmal atrial fibrillation (PAF) from ECG recordings taken during sinus rhythm, addressing a major diagnostic blind spot. The model was trained...
Ovarian cancer mechanisms: DJ‑1 autophagy link and lncRNA m6A regulation
Two independent studies identified molecular drivers that promote ovarian cancer progression. One team showed that the oncogene DJ‑1 regulates autophagy through the JNK signaling pathway,...
Multi‑omics spatial map identifies lung repair niches in pediatric ARDS
A multi‑omics study led by Song, Liu, Bai and colleagues in the Journal of Translational Medicine profiled spatial compartments in pediatric acute respiratory distress syndrome (ARDS) to identify...
Maternal methylation signatures flag gestational diabetes across pregnancy
An interdisciplinary team reported DNA methylation signatures in maternal blood that associate with gestational diabetes at multiple pregnancy stages. The study tracked methylation changes...
FDA clears Diasorin four‑plex assay — molecular PCR goes point‑of‑care
The FDA issued a 510(k) clearance and a CLIA waiver for Diasorin’s four‑plex molecular assay on the Liaison Nes platform, enabling rapid differentiation of Flu A/B, RSV and SARS‑CoV‑2 at the point...
White House proposes 40% NIH cut: researchers brace for disruptions
A detailed retrospective traces the NIH’s origins and warns that widespread grant terminations in 2025 and a White House proposal to cut the NIH budget by 40% for 2026 threaten the agency’s...
New antibodies neutralize Marburg...and Ravn
Researchers reported in npj Viruses the discovery of potent cross‑neutralizing antibodies that can neutralize both Marburg virus and the closely related Ravn virus. The antibodies target conserved...
CAR‑T vs bispecific antibodies: meta‑analysis compares efficacy in relapsed B‑cell NHL
A new meta‑analysis aggregated clinical data comparing CAR‑T cell therapies and bispecific antibody treatments in relapsed or refractory indolent B‑cell non‑Hodgkin’s lymphoma. The study performs...
AI flags paroxysmal AF from sinus‑rhythm ECGs — new detection software
A research team developed AI software designed to detect paroxysmal atrial fibrillation (PAF) from ECG traces recorded during sinus rhythm, addressing a key diagnostic blind spot for intermittent...
Conformal silicon Hall sensors...catch 3D tumors early
A multidisciplinary team published a conformal, ultrathin crystalline‑silicon Hall sensor array that enables early‑stage monitoring of three‑dimensional tumor tissues. Reported in npj Flexible...
RNA‑guided STAT3 reprograms CD4+ T cells in NSCLC — immunotherapy angle
Researchers uncovered a mechanism by which RNA‑guided modulation of STAT3 influences CD4+ T helper cell fate in non‑small cell lung cancer, reshaping epigenetic and epitranscriptomic programs. The...
CGMs cut costs ~20% but 80% of eligible patients still don’t use them
A new analysis reported that continuous glucose monitors (CGMs) reduce overall healthcare costs by roughly 20% for insulin‑dependent diabetes patients—primarily by cutting hospitalizations and ED...
Multi‑omics maps lung repair niches in pediatric ARDS — distinct spatial compartments found
A multi‑omics spatial study in pediatric acute respiratory distress syndrome (ARDS) identified discrete lung compartments associated with tissue repair, providing a molecular atlas of cellular...
LncRNA CYTOR drives metastasis and drug resistance in triple‑negative breast cancer
Investigators reported that the long non‑coding RNA CYTOR modulates pathways linked to metastasis and chemoresistance in triple‑negative breast cancer (TNBC), revealing a potential molecular lever...
FDA approves Yartemlea — first therapy for fatal stem‑cell transplant complication
The FDA granted approval to Omeros’s complement inhibitor Yartemlea for treating a severe and potentially fatal complication of hematopoietic stem cell transplants. The decision marks the first...
CMS launches Medicare model: expands GLP‑1 coverage for weight‑loss drugs
The Centers for Medicare & Medicaid Services unveiled a voluntary payment model designed to broaden Medicare coverage of GLP‑1 agonists used for weight loss. CMS framed the model as a step to...
Potent antibodies neutralize Marburg... cross‑protection against Ravn virus
Researchers reported discovery of a class of potent cross‑neutralizing monoclonal antibodies active against Marburg virus and the related Ravn virus, with results published in npj Viruses. The...
CAR‑T vs bispecifics — meta‑analysis maps outcomes in relapsed B‑cell lymphoma
A new meta‑analysis compared Chimeric Antigen Receptor T‑cell (CAR‑T) therapy with bispecific antibody therapy for relapsed or refractory indolent B‑cell non‑Hodgkin’s lymphoma. The pooled...
Smart AAVs: tumor‑responsive vectors boost targeting precision
Researchers introduced an intelligent design framework for adeno‑associated virus (AAV) vectors that dynamically respond to tumor microenvironment signals to enhance tumor targeting and reduce...
Ultrathin silicon Hall sensors detect 3‑D tumors — early‑stage tissue monitoring
A team developed a conformal, ultrathin crystalline‑silicon Hall sensor array intended for early‑stage monitoring of three‑dimensional tumor tissues, with the work reported in npj Flexible...